A bioactive gypenoside (GP-14) alleviates neuroinflammation and blood brain barrier (BBB) disruption by inhibiting the NF-κB signaling pathway in a mouse high-altitude cerebral edema (HACE) model - Concepedia

Concepedia

Publication | Open Access

A bioactive gypenoside (GP-14) alleviates neuroinflammation and blood brain barrier (BBB) disruption by inhibiting the NF-κB signaling pathway in a mouse high-altitude cerebral edema (HACE) model

DOI Full Paper Access

52

Citations

16

References

2022

Year

Yanan Geng, Jun‐Li Yang, Xiang Cheng, Ying Han, Feng Yan, Chengbo Wang, Xiufang Jiang, Xian‐Hua Meng, Ming Fan, Ming Zhao,

International Immunopharmacology

Abstract

Taken together, our results demonstrated that GP-14 exhibited prominent protective roles against neuroinflammation and BBB disruption in a mouse HACE model. GP-14 could be a potential choice for the treatment of HACE in the future.

References

	Year	Citations

Page 1